SCHEMBL6487474

SCHEMBL6487474

CCOC(=O)C(F)(F)C(O)c1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 1/20 0.52
GABBR1 Q9UBS5 1/20 0.52
ALDH1A1 P00352 2/20 0.51
ALOX15 P16050 1/20 0.47
KMT2A Q03164 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.43
CES2 O00748 1/20 0.42
ACHE P22303 1/20 0.42
CES1 P23141 1/20 0.42
TSHR P16473 2/20 0.42
ABCB11 O95342 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR2A P28223 1/20 0.42
PMP22 Q01453 1/20 0.42
PPARA Q07869 1/20 0.42
GLA P06280 1/20 0.40
HDAC3 O15379 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11507071 0.85 ALOX15 (0.49) GABBR2GABBR1ALDH1A1ALOX15KMT2A
SCHEMBL29570205 0.85 MAPT (0.46) ALDH1A1KMT2AGAAHPGDCES2
SCHEMBL6487847 0.84 ALDH1A1 (0.50) GABBR2GABBR1ALDH1A1ALOX15KMT2A
SCHEMBL27167866 0.84 NPSR1 (0.44) GABBR2GABBR1ALDH1A1KMT2AGAA
SCHEMBL3627581 0.84 LMNA (0.46) GABBR2GABBR1ALDH1A1ALOX15KMT2A
SCHEMBL25220032 0.84 ABCB11 (0.54) ALDH1A1KMT2AL3MBTL1GAATSHR
SCHEMBL1143435 0.83 POLB (0.48) ALDH1A1TSHRNPSR1
SCHEMBL20267902 0.82 GABBR2 (0.40) GABBR2GABBR1ALDH1A1ALOX15KMT2A
SCHEMBL10021191 0.81 TAAR1 (0.41) ALDH1A1KMT2APPARAHDAC4HDAC6
SCHEMBL8305982 0.81 NAMPT (0.40) KMT2AGAATSHRABCB11CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924391-B2 Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-02 US disclosed
US-20020037875-A1 Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2002-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020037875-A1 Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors PLA2G4B, PLA2G4A, PLA2G1B GABBR2 3003/4885GABBR1 2811/4885ALDH1A1 1718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.